Mesenchymal Stem Cells Global Market Report 2024

Description

Mesenchymal stem cells (MSCs) represent a type of multipotent adult stem cells distributed across various tissues in the body, including bone marrow, adipose tissue, umbilical cord blood, and dental pulp. These cells possess the capacity to differentiate into diverse cell types, including osteoblasts (bone cells) and chondrocytes (cartilage cells), rendering them valuable in treating various conditions such as bone and cartilage repair, myocardial infarction, and neurological disorders.

The primary types of mesenchymal stem cells are autologous and allogeneic. Autologous pertains to medical procedures where cells, tissues, or substances are obtained from an individual and then reintroduced into the same individual. Various product types are available, including cells and cell lines, kits, media and reagents, among others, along with different workflow types such as cell sourcing and isolation, culture and cryopreservation, differentiation, and characterization. These are utilized for several indications, including bone and cartilage repair, cardiovascular diseases, inflammatory and immunological diseases, liver diseases, cancer, GvHD, among others, and across various applications such as disease modeling, drug development and discovery, stem cell banking, tissue engineering, and toxicology studies.

The mesenchymal stem cells market research report is one of a series of new reports from The Business Research Company that provides mesenchymal stem cells market statistics, including mesenchymal stem cells industry global market size, regional shares, competitors with a mesenchymal stem cells market share, detailed mesenchymal stem cells market segments, market trends, and opportunities, and any further data you may need to thrive in the mesenchymal stem cells industry. This mesenchymal stem cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry

The mesenchymal stem cells market size has grown rapidly in recent years. It will grow from $3.00 billion in 2023 to $3.38 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The expansion observed during the historical period can be attributed to several factors. These include the paradigm shift towards regenerative medicine, collaborative research endeavors, heightened public awareness of stem cell research, patient advocacy efforts, international collaboration, and initiatives aimed at standardization.

The mesenchymal stem cells market size is expected to see rapid growth in the next few years. It will grow to $5.45 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The projected growth in the forecast period can be attributed to several factors, including ongoing advancements in genetic engineering technologies, the increasing adoption of personalized medicine approaches, the integration of artificial intelligence (AI) and data analytics, advancements in biomaterials science and 3D bioprinting technologies, the development of microfluidic devices and organ-on-a-chip models, as well as the adoption of next-generation manufacturing technologies. Major trends expected during this period include the expansion of bioprinting and tissue engineering, advancements in gene editing technologies, the broadening of clinical applications, the emergence of combination therapies, and the utilization of mesenchymal stem cell-derived extracellular vesicles (EVs).

The mesenchymal stem cells (MSC) market is anticipated to experience growth driven by the increasing awareness surrounding regenerative medicine. Regenerative medicine, an emerging interdisciplinary field, aims to restore impaired cellular, tissue, or organ function caused by various factors such as disease, injury, or aging. This growth is fueled by rising clinical trials, the prevalence of chronic and age-related conditions, and the trend towards personalized medicine. Mesenchymal stem cells (MSCs) hold significant promise in regenerative medicine due to their capacity to differentiate into various cell types, modulate immune responses, and facilitate tissue repair and regeneration across a spectrum of medical conditions. For instance, a report by the Alliance for Regenerative Medicine revealed a substantial increase in therapeutic developers engaged in cells, gene, and tissue-engineering therapies worldwide in Q1 2023 compared to Q1 2022. Additionally, financing for regenerative medicine and advanced therapies has seen a notable uptick, underscoring the growing awareness and investment in this field.

Leading companies in the mesenchymal stem cells (MSCs) market are leveraging innovative technologies, such as GMP-compliant isolation, to enhance their market presence. GMP-compliant isolation involves isolating cells, including MSCs, in accordance with Good Manufacturing Practice regulations to ensure consistent production and quality control. For example, PromoCell recently introduced PromoExQ MSC Growth Medium XF, a serum- and xeno-free medium specifically formulated for the expansion of human MSCs in GMP-regulated environments. This medium adheres to the highest quality standards and is EXCiPACT GMP-certified, facilitating consistent growth and maintenance of MSCs sourced from various origins such as bone marrow, umbilical cord matrix, and adipose tissue.

In July 2021, Brooklyn ImmunoTherapeutics acquired Novellus Therapeutics for $125 million, bolstering its position as a platform company with a pipeline of advanced cellular, gene editing, and cytokine programs. Novellus Therapeutics, a developer of next-generation engineered mesenchymal stem cells, aligns with Brooklyn's vision to advance innovative therapies in the regenerative medicine space.

Major companies operating in the mesenchymal stem cells market are Thermo Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton, Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc., Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group, Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories, PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem Therapeutics Inc., American Cryostem Corporation

North America was the largest region in the mesenchymal stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mesenchymal stem cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mesenchymal stem cells market consists of revenues earned by entities by providing services such as cell isolation and culture techniques, cryopreservation and storage, custom cell development, and MSC-based therapeutics development. The market value includes the value of related goods sold by the service provider or included within the service offering. The mesenchymal stem cells market also includes sales of MSC differentiation inducers, scaffolds and matrices, MSC-derived exosomes, and cryopreservation agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mesenchymal Stem Cells Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mesenchymal stem cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mesenchymal stem cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mesenchymal stem cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Autologous; Allogeneic
2) By Product Type: Cells And Cell Lines; Kits, Media And Reagents; Other Product Types
3) By Workflow Type: Cell Sourcing And Isolation; Culture And Cryopreservation; Differentiation; Characterization
4) By Indication: Bone And Cartilage Repair; Cardiovascular Diseases; Inflammatory And Immunological Diseases; Liver Diseases; Cancer; GvHD; Other Indications
5) By Application: Disease Modeling; Drug Development And Discovery; Stem Cell Banking; Tissue Engineering; Toxicology Studies; Other Applications
Companies Mentioned: Thermo Fischer Scientific Inc.; Danaher Corporation; Merck KgaA; Becton, Dickinson, and Company; Fujifilm Holdings Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18667

1. Executive Summary

2. Mesenchymal Stem Cells Market Characteristics

3. Mesenchymal Stem Cells Market Trends And Strategies

4. Mesenchymal Stem Cells Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Mesenchymal Stem Cells Market Size and Growth

5.1. Global Mesenchymal Stem Cells Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Mesenchymal Stem Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Mesenchymal Stem Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Mesenchymal Stem Cells Market Segmentation

6.1. Global Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Autologous
Allogeneic
6.2. Global Mesenchymal Stem Cells Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cells And Cell Lines
Kits, Media And Reagents
Other Product Types
6.3. Global Mesenchymal Stem Cells Market, Segmentation By Workflow Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cell Sourcing And Isolation
Culture And Cryopreservation
Differentiation
Characterization
6.4. Global Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bone And Cartilage Repair
Cardiovascular Diseases
Inflammatory And Immunological Diseases
Liver Diseases
Cancer
GvHD
Other Indications
6.5. Global Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Disease Modeling
Drug Development And Discovery
Stem Cell Banking
Tissue Engineering
Toxicology Studies
Other Applications

7. Mesenchymal Stem Cells Market Regional And Country Analysis

7.1. Global Mesenchymal Stem Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Mesenchymal Stem Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Mesenchymal Stem Cells Market

8.1. Asia-Pacific Mesenchymal Stem Cells Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Mesenchymal Stem Cells Market

9.1. China Mesenchymal Stem Cells Market Overview
9.2. China Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Mesenchymal Stem Cells Market

10.1. India Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Mesenchymal Stem Cells Market

11.1. Japan Mesenchymal Stem Cells Market Overview
11.2. Japan Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Mesenchymal Stem Cells Market

12.1. Australia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Mesenchymal Stem Cells Market

13.1. Indonesia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Mesenchymal Stem Cells Market

14.1. South Korea Mesenchymal Stem Cells Market Overview
14.2. South Korea Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Mesenchymal Stem Cells Market

15.1. Western Europe Mesenchymal Stem Cells Market Overview
15.2. Western Europe Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Mesenchymal Stem Cells Market

16.1. UK Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Mesenchymal Stem Cells Market

17.1. Germany Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Mesenchymal Stem Cells Market

18.1. France Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Mesenchymal Stem Cells Market

19.1. Italy Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Mesenchymal Stem Cells Market

20.1. Spain Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Mesenchymal Stem Cells Market

21.1. Eastern Europe Mesenchymal Stem Cells Market Overview
21.2. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Mesenchymal Stem Cells Market

22.1. Russia Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Mesenchymal Stem Cells Market

23.1. North America Mesenchymal Stem Cells Market Overview
23.2. North America Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Mesenchymal Stem Cells Market

24.1. USA Mesenchymal Stem Cells Market Overview
24.2. USA Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Mesenchymal Stem Cells Market

25.1. Canada Mesenchymal Stem Cells Market Overview
25.2. Canada Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Mesenchymal Stem Cells Market

26.1. South America Mesenchymal Stem Cells Market Overview
26.2. South America Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Mesenchymal Stem Cells Market

27.1. Brazil Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Mesenchymal Stem Cells Market

28.1. Middle East Mesenchymal Stem Cells Market Overview
28.2. Middle East Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Mesenchymal Stem Cells Market

29.1. Africa Mesenchymal Stem Cells Market Overview
29.2. Africa Mesenchymal Stem Cells Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Mesenchymal Stem Cells Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Mesenchymal Stem Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Mesenchymal Stem Cells Market Competitive Landscape And Company Profiles

30.1. Mesenchymal Stem Cells Market Competitive Landscape
30.2. Mesenchymal Stem Cells Market Company Profiles
- 30.2.1. Thermo Fischer Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Danaher Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck KgaA
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton, Dickinson, and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Fujifilm Holdings Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Mesenchymal Stem Cells Market Other Major And Innovative Companies

31.1. Corning Inc.
31.2. Daiichi Sankyo
31.3. Lonza Group
31.4. Terumo Corporation
31.5. Sartorius AG
31.6. Getinge AB
31.7. Bio-Rad Laboratories
31.8. Eppendorf AG
31.9. Bio-Techne Corporation
31.10. STEMCELL Technologies Inc.
31.11. Miltenyi Biotec GmBH
31.12. Takara Bio Group
31.13. Organogenesis Holdings Inc.
31.14. Vericel Corporation
31.15. HiMedia Laboratories

32. Global Mesenchymal Stem Cells Market Competitive Benchmarking

33. Global Mesenchymal Stem Cells Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Mesenchymal Stem Cells Market

35. Mesenchymal Stem Cells Market Future Outlook and Potential Analysis

35.1 Mesenchymal Stem Cells Market In 2028 - Countries Offering Most New Opportunities
35.2 Mesenchymal Stem Cells Market In 2028 - Segments Offering Most New Opportunities
35.3 Mesenchymal Stem Cells Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer